Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE1B | Q01064 | 2/20 | 0.34 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.33 |
| ▸ | PDE2A | O00408 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2454685 | 0.92 | DAO (0.36) | PDE1BPDE2AMEN1HPGDKMT2A | |
| SCHEMBL2456947 | 0.91 | DAO (0.33) | PDE1BMEN1KMT2ALMNAPKM | |
| SCHEMBL2457421 | 0.91 | ALKBH3 (0.36) | PDE1BMEN1HPGDKMT2AKDM5A | |
| SCHEMBL2456758 | 0.87 | KDM4A (0.38) | PDE2AKDM5AKDM5B | |
| SCHEMBL2455233 | 0.86 | DAO (0.38) | LMNAPKM | |
| SCHEMBL2460223 | 0.84 | ENPP1 (0.43) | PDE1B | |
| SCHEMBL2455163 | 0.84 | ENPP1 (0.43) | EGLN2HPGDLMNAPKMPOLB | |
| SCHEMBL2457055 | 0.84 | AR (0.35) | PDE2ALMNAPKM | |
| SCHEMBL2464959 | 0.80 | ENPP1 (0.31) | — | |
| SCHEMBL2460016 | 0.80 | CCR2 (0.36) | PDE2AMEN1HPGDKMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011114148-A1 | 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2011-09-22 | — | — | WO | claimed |
| WO-2011114148-A1 | 4H- [1, 2, 4] TRIAZOLO [5, 1 -B] PYRIMIDIN-7 -ONE DERIVATIVES AS CCR2B RECEPTOR ANTAGONISTS | ASTRAZENECA AB (SE) | 2011-09-22 | — | — | WO | disclosed |